ChiRhoClin, Inc., a Maryland based family run corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin, Inc. is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products. Our mission is to develop orphan drug products for the GI and Radiological community. Our emphasis is to develop orphan drug products that will diagnose and treat pancreatic gastrointestinal diseases and to encourage research in the pancreatic area through our small grant program. Our lead product, ChiRhoStim® (Human Secretin for Injection), is approved for Pancreatic Function Testing, Facilitating Cannulation during ERCP’s, and Gastrinoma Testing. Finally, you can improve your MRCP images with Secretin-enhanced MRCP or use EUS combined with Secretin to perform an EUS Pancreatic Function Test. |
